Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2 Study Evaluating the Efficacy of Anti-CD38 Antibody in Combination With KRAS Vaccine and Anti-PD-1 Antibody in Subjects With Pancreatic Ductal Adenocarcinoma and Refractory Non-Small Cell Lung Cancer

The goal of this clinical trial is to test the safety and tolerability of anti-CD38 monoclonal antibody (mAb), daratumumab, in combination with KRAS vaccine (T…

Pancreatic Ductal AdenocarcinomaRefractory Non-Small Cell Lung Cancer

Georgetown UniversityNCT06015724